Cryofocus Medtech (Shanghai) Co., Ltd. (HKG:6922)

HKG:6922 Statistics

Total Valuation

HKG:6922 has a market cap or net worth of HKD 1.57 billion. The enterprise value is 1.54 billion.

Market Cap	1.57B
Enterprise Value	1.54B

Important Dates

The next estimated earnings date is Friday, March 27, 2026.

Earnings Date	Mar 27, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:6922 has 239.11 million shares outstanding.

Current Share Class	143.44M
Shares Outstanding	239.11M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	16.43%
Owned by Institutions (%)	1.01%
Float	36.18M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	16.81
PB Ratio	24.18
P/TBV Ratio	24.88
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-18.52
EV / Sales	16.53
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-35.30

Financial Position

The company has a current ratio of 1.85, with a Debt / Equity ratio of 0.64.

Current Ratio	1.85
Quick Ratio	1.04
Debt / Equity	0.64
Debt / EBITDA	n/a
Debt / FCF	-0.96
Interest Coverage	-57.58

Financial Efficiency

Return on equity (ROE) is -89.12% and return on invested capital (ROIC) is -47.09%.

Return on Equity (ROE)	-89.12%
Return on Assets (ROA)	-35.69%
Return on Invested Capital (ROIC)	-47.09%
Return on Capital Employed (ROCE)	-99.75%
Revenue Per Employee	518,438
Profits Per Employee	-462,730
Employee Count	276
Asset Turnover	0.49
Inventory Turnover	1.12

Taxes

In the past 12 months, HKG:6922 has paid 153,409 in taxes.

Income Tax	153,409
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -12.11% in the last 52 weeks. The beta is -1.08, so HKG:6922's price volatility has been lower than the market average.

Beta (5Y)	-1.08
52-Week Price Change	-12.11%
50-Day Moving Average	6.35
200-Day Moving Average	5.66
Relative Strength Index (RSI)	52.32
Average Volume (20 Days)	120,110

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:6922 had revenue of HKD 93.32 million and -83.29 million in losses. Loss per share was -0.35.

Revenue	93.32M
Gross Profit	62.94M
Operating Income	-107.77M
Pretax Income	-90.30M
Net Income	-83.29M
EBITDA	-101.30M
EBIT	-107.77M
Loss Per Share	-0.35

Balance Sheet

The company has 69.77 million in cash and 41.79 million in debt, with a net cash position of 27.99 million or 0.12 per share.

Cash & Cash Equivalents	69.77M
Total Debt	41.79M
Net Cash	27.99M
Net Cash Per Share	0.12
Equity (Book Value)	64.88M
Book Value Per Share	0.26
Working Capital	56.82M

Cash Flow

In the last 12 months, operating cash flow was -43.14 million and capital expenditures -551,177, giving a free cash flow of -43.69 million.

Operating Cash Flow	-43.14M
Capital Expenditures	-551,177
Free Cash Flow	-43.69M
FCF Per Share	-0.18

Margins

Gross margin is 67.45%, with operating and profit margins of -115.49% and -89.25%.

Gross Margin	67.45%
Operating Margin	-115.49%
Pretax Margin	-96.76%
Profit Margin	-89.25%
EBITDA Margin	-108.55%
EBIT Margin	-115.49%
FCF Margin	n/a

Dividends & Yields

HKG:6922 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-5.31%
FCF Yield	-2.79%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:6922 has an Altman Z-Score of 0.89 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.89
Piotroski F-Score	3